The evaluate discusses 58 peptides in different clinical phases, indicating a strong pipeline of peptide therapies targeting PPIs. Clinical trials and preclinical studies are highlighted, demonstrating the efficacy of peptide vaccines in inducing an immune reaction, with the possible to enhance survival charges for HCC clients. Systematic Evaluate and Meta-Examination: https://ashleyz829avq5.idblogmaker.com/profile